Literature DB >> 27129923

"No patient left behind": an alternative to "the War on Cancer" metaphor.

Bryan T Oronsky1, Corey A Carter2, Arnold L Oronsky3, Michael E Salacz4, Tony Reid5.   

Abstract

The War on Cancer began with President Nixon's National Cancer Act of 1971. Treatment-related 'collateral damage' to healthy cells and tissues that reduces quality of life is an unfortunate but inevitable consequence of the overriding imperative to "win the war." In the face of a quality of life decrement, patients are encouraged with militaristic turns-of-phrases to "soldier on," "fight it," and "never say die." Rather than this dysfunctional imagery, which relegates patients to the status of mere cogs in the ever-grinding wheel of the clinical war machine and encourages the practice of disease-centered medicine, we propose an alternate analogy/organizing principle borrowed from the realm of education: No patient left behind.

Entities:  

Keywords:  Chemotherapy; Maximally tolerated dose; No patient left behind; Resistance; Toxicity; War on Cancer

Mesh:

Year:  2016        PMID: 27129923     DOI: 10.1007/s12032-016-0769-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  3 in total

1.  A change of strategy in the war on cancer.

Authors:  Robert A Gatenby
Journal:  Nature       Date:  2009-05-28       Impact factor: 49.962

2.  The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy.

Authors:  Andrew F Read; Troy Day; Silvie Huijben
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

3.  Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.

Authors:  Tony Reid; Bryan Oronsky; Jan Scicinski; Curt L Scribner; Susan J Knox; Shoucheng Ning; Donna M Peehl; Ron Korn; Meaghan Stirn; Corey A Carter; Arnold Oronsky; Michael J Taylor; William L Fitch; Pedro Cabrales; Michelle M Kim; Howard A Burris; Christopher D Lao; Nacer E D Abrouk; Gary R Fanger; Jeffrey R Infante
Journal:  Lancet Oncol       Date:  2015-08-19       Impact factor: 41.316

  3 in total
  7 in total

1.  The Art of War and oncology: applying the principles of strategy and tactics to greater effect in the era of targeted therapy.

Authors:  Emil Lou
Journal:  Ann Transl Med       Date:  2018-05

Review 2.  Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.

Authors:  Anne M Macpherson; Simon C Barry; Carmela Ricciardelli; Martin K Oehler
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

3.  A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001.

Authors:  Bryan Oronsky; Scott Caroen; Karen Zeman; Mary Quinn; Christina Brzezniak; Jan Scicinski; Pedro Cabrales; Tony R Reid; Jane B Trepel; Nacer D Abrouk; Christopher Larson; Arnold Oronsky; Harry E Lybeck; Regina M Day; Corey A Carter
Journal:  Clin Med Insights Oncol       Date:  2016-11-06

4.  Association of Neighborhood Deprivation Index With Success in Cancer Care Crowdfunding.

Authors:  Elisabeth R Silver; Han Q Truong; Sassan Ostvar; Chin Hur; Nicholas P Tatonetti
Journal:  JAMA Netw Open       Date:  2020-12-01

5.  Cancer as the "perfect storm"? A qualitative study of public attitudes to health conditions.

Authors:  Liz Morrell; Suzanne Sayuri Ii; Sarah Wordsworth; Roger Wilson; Sian Rees; Richard Barker
Journal:  Health Sci Rep       Date:  2017-10-27

6.  Serious Illness Conversations: Paving the Road with Metaphors.

Authors:  David Hui; Donna S Zhukovsky; Eduardo Bruera
Journal:  Oncologist       Date:  2018-01-25

7.  Cancer-related stigma in the USA and Israeli mass media: an exploratory study of structural stigma.

Authors:  Michal Soffer
Journal:  J Cancer Surviv       Date:  2022-02-02       Impact factor: 4.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.